Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03823742 · ClinicalTrials.gov registry record · NA

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

A NA study of Irritable Bowel Syndrome and Functional Gastrointestinal Disorders, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT03823742 is a NA study of Irritable Bowel Syndrome and Functional Gastrointestinal Disorders that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 250 participants, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03823742, a NA study of Irritable Bowel Syndrome and Functional Gastrointestinal Disorders, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

Conditions Studied

Irritable Bowel Syndrome Functional Gastrointestinal Disorders Functional Abdominal Pain Syndrome Functional Bowel Disorder Functional Abdominal Pain Disorders Functional Abdominal Pain

Interventions

  • OTHER Cognitive Behavioral Therapy
  • OTHER Low FODMAP Diet

Study Locations (2)

Texas

  • Children's Nutrition Research Center - Houston
  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2019-02-22
Est. Completion 2025-12-31
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03823742

The ClinicalTrials.gov registry entry for NCT03823742 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT03823742 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03823742 about?

NCT03823742 is a clinical study titled "Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?". The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

What is the current status of trial NCT03823742?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2019-02-22. Estimated completion is 2025-12-31.

What conditions does trial NCT03823742 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome, Functional Gastrointestinal Disorders, Functional Abdominal Pain Syndrome, Functional Bowel Disorder, Functional Abdominal Pain Disorders.

What interventions are being tested in trial NCT03823742?

The interventions under investigation include: Cognitive Behavioral Therapy (OTHER), Low FODMAP Diet (OTHER).

Who is sponsoring clinical trial NCT03823742?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03823742 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Irritable Bowel Syndrome

All registered trials for this condition

Functional Gastrointestinal Disorders

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.